Commandité

Unlocking the Potential of Antibody Drug Conjugates: Market Insights and Innovations

https://www.marketsandmarkets.com/Market-Reports/antibody-drug-conjugates-market-122857391.html

The antibody drug conjugates market is projected to reach USD 19.8 Billion by 2028 from USD 9.7 Billion in 2023, at a CAGR of 15.2% during the forecast period. Growth in the antibody drug conjugates market can be attributed to factors such as the collaborations and partnerships among market players for the development of new ADCs, and the rising number of government approvals for antibody drug conjugates.

The global antibody drug conjugates market is highly competitive. The prominent players operating in this market include F. Hoffmann-La Roche Ltd (Switzerland), Daiichi Sankyo Company, Limited (Japan), Seagen Inc. (US), Gilead Sciences, Inc. (US), Takeda Pharmaceutical Company Limited (Japan), Pfizer Inc. (US), Astellas Pharma Inc (Japan), AstraZeneca (UK), ADC Therapeutics SA (Switzerland), ImmunoGen, Inc. (US), and Zydus Group (India), among others.
Unlocking the Potential of Antibody Drug Conjugates: Market Insights and Innovations https://www.marketsandmarkets.com/Market-Reports/antibody-drug-conjugates-market-122857391.html The antibody drug conjugates market is projected to reach USD 19.8 Billion by 2028 from USD 9.7 Billion in 2023, at a CAGR of 15.2% during the forecast period. Growth in the antibody drug conjugates market can be attributed to factors such as the collaborations and partnerships among market players for the development of new ADCs, and the rising number of government approvals for antibody drug conjugates. The global antibody drug conjugates market is highly competitive. The prominent players operating in this market include F. Hoffmann-La Roche Ltd (Switzerland), Daiichi Sankyo Company, Limited (Japan), Seagen Inc. (US), Gilead Sciences, Inc. (US), Takeda Pharmaceutical Company Limited (Japan), Pfizer Inc. (US), Astellas Pharma Inc (Japan), AstraZeneca (UK), ADC Therapeutics SA (Switzerland), ImmunoGen, Inc. (US), and Zydus Group (India), among others.
WWW.MARKETSANDMARKETS.COM
Antibody Drug Conjugates Market Size, Share, Trends and Revenue Forecast [Latest]
The global antibody drug conjugates market in terms of revenue was estimated to be worth $9.7 billion in 2023 and is poised to reach $19.8 billion by 2028, growing at a CAGR of 15.2% from 2023 to 2028.
0 Commentaires 0 parts
Commandité

Commandité


Don't forget, ads time: PentaVerge | AQU | Debwan | ICICTE | Nasseej | ESol | OUST | CorpSNet | PoemsBook | TopDeals | TheReaderView